Paper5081602
Daunorubicin metabolism in acute nonlymphocytic leukemia.
Huffman DH and 2 others. Clin Pharmacol Ther, 1972. Cited by 95 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Daunorubicin metabolism in acute nonlymphocytic leukemia. Papers, record 5081602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5081602
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Daunorubicin | Major topic |
| Leukemia | Major topic |
| Adipose Tissue | |
| Chromatography, Thin Layer | |
| Half-Life | |
| Humans | |
| Injections, Intravenous | |
| Kidney | |
| Liver | |
| Lung | |
| Muscles | |
| Myocardium | |
| Pancreas | |
| Spectrometry, Fluorescence | |
| Spleen |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,689,693 | The pharmacokinetics of therapeutic arsenic trioxide in acute promyelocytic leukemia patients. | Leuk Lymphoma | 2022 | https://conductscience.org/library/papers/34689693 | PubMed |
| 20,861,736 | Pharmacogenomics in pediatric leukemia. | Curr Opin Pediatr | 2010 | https://conductscience.org/library/papers/20861736 | PubMed |
| 12,882,589 | Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemia. | Clin Pharmacokinet | 2003 | https://conductscience.org/library/papers/12882589 | PubMed |
| 7,860,226 | Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome). | Invest New Drugs | 1994 | https://conductscience.org/library/papers/7860226 | PubMed |
| 7,459,213 | Heparin does not modify plasma daunomycin disappearance in acute leukaemia patients. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7459213 | PubMed |
| 7,261,253 | Pharmacokinetics of daunorubicin after administration as free drug or as DNA complex in leukemic patients. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7261253 | PubMed |
| 6,189,661 | Clinical pharmacokinetics of commonly used anticancer drugs. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6189661 | PubMed |
| 4,524,632 | Adriamycin and daunorubicin inhibition of mutant T4 DNA polymerases. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4524632 | PubMed |
| 3,891,121 | Uptake and metabolism of daunorubicin by human myelocytic cells. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3891121 | PubMed |
| 3,600,054 | Plasma levels of daunorubicin metabolites and the outcome of ANLL therapy. | Med Oncol Tumor Pharmacother | 1987 | https://conductscience.org/library/papers/3600054 | PubMed |
| 3,471,265 | Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3471265 | PubMed |
| 1,760,856 | Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs. | Cancer Chemother Pharmacol | 1991 | https://conductscience.org/library/papers/1760856 | PubMed |
| 1,107,513 | Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references. | J Pharmacokinet Biopharm | 1975 | https://conductscience.org/library/papers/1107513 | PubMed |
| 799,549 | Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure. | Clin Pharmacokinet | 1976 | https://conductscience.org/library/papers/799549 | PubMed |
| 535,134 | Human pharmacokinetics of the daunorubicin-DNA complex. An alternative view of the lysosomotropic theory. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/535134 | PubMed |
| 498,413 | Liquid chromatographic monitoring of daunorubicin and daunorubicinol in plasma from leukemic patients treated with daunorubicin or the daunorubicin-DNA complex. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/498413 | PubMed |
| 119,583 | Comparative metabolism and excretion of adriamycin in man, monkey, and rat. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/119583 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5081602
GET https://conductscience.org/api/papers/v1/5081602/authors